SCHEMBL4970079

SCHEMBL4970079

Cc1onc(-c2cccc(F)c2)c1-c1c[nH]c(-c2cccc(C(=O)NCC3CC3)c2)n1

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 14/20 0.57
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
CNR2 P34972 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
GABRA1 P14867 1/20 0.40
AR P10275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4972400 0.94 GABRA5 (0.58) GABRA5GABRA1
SCHEMBL4973108 0.92 GABRA5 (0.51) GABRA5NPSR1GABRA1
SCHEMBL4971806 0.87 GABRA5 (0.53) GABRA5
SCHEMBL4972209 0.86 GABRA5 (0.50) GABRA5
SCHEMBL4973770 0.86 GABRA5 (0.50) GABRA5
SCHEMBL4973396 0.84 GABRA5 (0.54) GABRA5NPSR1GABRA1
SCHEMBL4970995 0.84 GABRA5 (0.56) GABRA5GABRA1
SCHEMBL4973225 0.81 SMN1; SMN2 (0.44) GABRA5
SCHEMBL4971020 0.81 GABRA5 (0.55) GABRA5
SCHEMBL2471840 0.81 GABRA5 (0.56) GABRA5CYP1A2GAACYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968973-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-09-17 EP claimed
WO-2007074078-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-07-05 WO claimed
EP-1968973-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-09-17 EP disclosed
WO-2007074078-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-07-05 WO disclosed